The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges

Overall survival (OS) is considered the standard clinical endpoint to support effectiveness claims in new drug applications globally, particularly for lethal conditions such as cancer. However, the source and reliability of OS in the setting of clinical trials have seldom been doubted and discussed....

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huiyao, Tang, Yu, Yu, Yue, Yu, Anqi, Wu, Dawei, Fang, Hong, Wang, Shuhang, Sun, Chao, Wang, Xin, Fan, Qi, Fang, Yuan, Tang, Qiyu, Jiang, Ning, Du, Jingting, Miao, Huilei, Bai, Ying, Ma, Peiwen, Xing, Shujun, Cui, Dandan, Miao, Shuangman, Jiang, Yale, Zhu, Jingxiao, Zhu, Qi, Leng, Ye, Guo, Lan Wei, Liao, Shanmei, Shao, Yaguang, Song, Yinyin, Liu, Zeyuan, Hong, Minghuang, Luo, Suxia, Xu, Binghe, Lan, Gongtao, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678947/
https://www.ncbi.nlm.nih.gov/pubmed/36426285
http://dx.doi.org/10.1016/j.lanwpc.2022.100624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678947/
https://www.ncbi.nlm.nih.gov/pubmed/36426285
http://dx.doi.org/10.1016/j.lanwpc.2022.100624

Ejemplares similares